<DOC>
	<DOCNO>NCT02540707</DOCNO>
	<brief_summary>Background/Purpose : The overactive bladder syndrome ( OAB ) affect around 17 % female population . Antimuscarinics affect autonomic system , arterial stiffness psychosomatic distress . However , research new drug- mirabegron ( β3-agonist ) . Thus , aim study analyze between-group difference heart rate variability , cardio-ankle vascular index , ankle-brachial pressure index , psychosomatic distress , personality trait , family support clinical outcome mirabegron solifenacin group . Patients Methods : The investigator perform prospective randomize control study recruit 150 female OAB patient outpatient clinic Department Obstetrics Gynecology National Taiwan University Hospital . All OAB female patient ask complete Urgency Severity Scales , Overactive Bladder Symptoms Scores questionnaires , King 's Health questionnaire , UDI-6 &amp; IIQ-7 , Patient Health Questionnaire , brief symptom rating scale ( BSRS ) , Maudsley personality inventory ( MPI ) adaptability , partnership , growth , affection , resolve ( APGAR ) questionnaires , Sleep Dietary habit Questionnaire , standard 12-leads electrocardiography ( ECG ) , 5 minute Holter monitoring , cardio-ankle vascular index ( CAVI ) test , bladder diary , 20-min pad test , urodynamic study measurement urinary nerve growth factor level 12 week ' mirabegron versus solifenacin treatment . STATA software use statistical analysis . Possible Results : The investigator answer between-group difference heart rate variability , cardio-ankle vascular index , ankle-brachial pressure index , psychosomatic distress , personality trait , family support clinical outcome mirabegron solifenacin group . The conclusion important pre-treatment consultation .</brief_summary>
	<brief_title>Comparisons Effects Solifenacin Versus Mirabegron Autonomic System , Arterial Stiffness Psychosomatic Distress Clinical Outcomes</brief_title>
	<detailed_description />
	<mesh_term>Urinary Bladder , Overactive</mesh_term>
	<mesh_term>Solifenacin Succinate</mesh_term>
	<mesh_term>Mirabegron</mesh_term>
	<criteria>Women overactive bladder syndrome ≥20 yearold Urine retention , acute angle glaucoma , myasthenia gravis , ulcerative colitis , megacolon</criteria>
	<gender>Female</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>99 Years</maximum_age>
	<verification_date>April 2016</verification_date>
</DOC>